Rosen Law Firm Investigates Lufax Over Disclosure Claims Following Stock Decline

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Rosen Law Firm investigates Lufax for potential disclosure violations after auditor removal announcement triggered 13.8% stock decline. Class action lawsuit evaluation ongoing.

Rosen Law Firm Investigates Lufax Over Disclosure Claims Following Stock Decline

The Rosen Law Firm has initiated an investigation into potential securities law violations by Lufax Holding Ltd (NYSE: LU) following the company's announcement on January 27, 2025, regarding auditor removal and delays in filing its 2024 annual report. The disclosure triggered a significant market reaction, with the company's stock declining 13.8% in the trading session following the announcement.

The investigation centers on allegations that Lufax may have issued materially misleading or incomplete business information to investors prior to the January announcement. The law firm is examining whether the company's prior disclosures adequately reflected the circumstances that led to the auditor removal and reporting delays, which are typically significant corporate events that can indicate underlying financial or governance concerns.

The firm is currently evaluating the potential for a class action lawsuit on behalf of investors who experienced losses during the relevant period. Investors who have held positions in Lufax shares and suffered losses are being encouraged to contact the firm to discuss their legal rights and potential remedies. The investigation is ongoing as the firm gathers additional information regarding the company's disclosure practices and timeline of events.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 23

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON